QSAR Modeling and Prediction of Drug-Drug Interactions.
暂无分享,去创建一个
Marc C. Nicklaus | Alexander Tropsha | Denis Fourches | Alexey V. Zakharov | Eugene N. Muratov | Ekaterina V. Varlamova | Alexey A. Lagunin | Vladimir V. Poroikov | Victor E. Kuz'min | Alexander V. Dmitriev | A. Tropsha | V. Poroikov | A. Zakharov | D. Fourches | E. Muratov | A. Lagunin | M. Nicklaus | V. Kuz'min | A. Dmitriev | E. Varlamova
[1] Amy J Grizzle,et al. Development of computerized alerts with management strategies for 25 serious drug-drug interactions. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[2] T K Hazlet,et al. ORCA: OpeRational ClassificAtion of drug interactions. , 2001, Journal of the American Pharmaceutical Association.
[3] Alexey V Zakharov,et al. Computational tools and resources for metabolism-related property predictions. 2. Application to prediction of half-life time in human liver microsomes. , 2012, Future medicinal chemistry.
[4] Eugene N Muratov,et al. Per aspera ad astra: application of Simplex QSAR approach in antiviral research. , 2010, Future medicinal chemistry.
[5] Chitta Baral,et al. Discovering drug–drug interactions: a text-mining and reasoning approach based on properties of drug metabolism , 2010, Bioinform..
[6] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[7] Carol Friedman,et al. Drug-drug interaction through molecular structure similarity analysis , 2012, J. Am. Medical Informatics Assoc..
[8] V V Poroikov,et al. QNA-based ‘Star Track’ QSAR approach , 2009, SAR and QSAR in environmental research.
[9] Susumu Goto,et al. Network-Based Analysis and Characterization of Adverse Drug-Drug Interactions , 2011, J. Chem. Inf. Model..
[10] Kuo-Chen Chou,et al. Structure of cytochrome p450s and personalized drug. , 2009, Current medicinal chemistry.
[11] J. Wapner. Deadly Drug Combinations , 2015 .
[12] J. Kuhlmann,et al. Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug Development , 2001, Drug safety.
[13] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[14] Eugene N Muratov,et al. Existing and Developing Approaches for QSAR Analysis of Mixtures , 2012, Molecular informatics.
[15] A Tropsha,et al. QSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action , 2011, SAR and QSAR in environmental research.
[16] S. Vilar,et al. Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints , 2013, PloS one.
[17] Janette M Carpenter,et al. The Top 100 Drug Interactions: A Guide to Patient Management , 2002 .
[18] George Hripcsak,et al. Similarity-based modeling in large-scale prediction of drug-drug interactions , 2014, Nature Protocols.
[19] F. Guengerich. Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.
[20] Victor Kuzmin,et al. Hierarchical QSAR technology based on the Simplex representation of molecular structure , 2008, J. Comput. Aided Mol. Des..
[21] Russ B. Altman,et al. Discovery and Explanation of Drug-Drug Interactions via Text Mining , 2011, Pacific Symposium on Biocomputing.
[22] Atul J. Butte,et al. Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..
[23] Victor Kuzmin,et al. Application of Random Forest Approach to QSAR Prediction of Aquatic Toxicity , 2009, J. Chem. Inf. Model..
[24] Carol Friedman,et al. State of the art and development of a drug-drug interaction large scale predictor based on 3D pharmacophoric similarity. , 2014, Current drug metabolism.
[25] Igor V. Tetko,et al. Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis , 2008, J. Chem. Inf. Model..
[26] Shufeng Zhou,et al. Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring , 2007, Therapeutic drug monitoring.
[27] Marc C. Nicklaus,et al. QSAR Modeling of Imbalanced High-Throughput Screening Data in PubChem , 2014, J. Chem. Inf. Model..
[28] R. Altman,et al. Informatics confronts drug-drug interactions. , 2013, Trends in pharmacological sciences.
[29] Alexey V Zakharov,et al. Quantitative prediction of antitarget interaction profiles for chemical compounds. , 2012, Chemical research in toxicology.
[30] L. Saha,et al. Fixed dose drug combinations (FDCs): rational or irrational: a view point. , 2008, British journal of clinical pharmacology.
[31] E. Matthews,et al. Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence. , 2010, Regulatory toxicology and pharmacology : RTP.
[32] Robert P. Sheridan,et al. Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction , 2013, J. Chem. Inf. Model..
[33] Marc C. Nicklaus,et al. A New Approach to Radial Basis Function Approximation and Its Application to QSAR , 2014, J. Chem. Inf. Model..
[34] Vladimir Poroikov,et al. QSAR Modelling of Rat Acute Toxicity on the Basis of PASS Prediction , 2011, Molecular informatics.
[35] Wei Xie,et al. Computer-Aided Prediction of Rodent Carcinogenicity by PASS and CISOC-PSCT , 2009 .
[36] Alexey V Zakharov,et al. Synthesis, antifungal activity and QSAR study of 2-arylhydroxynitroindoles. , 2011, European journal of medicinal chemistry.
[37] E. Muratov,et al. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication. , 2007, Journal of medicinal chemistry.
[38] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[39] Anatoly G. Artemenko,et al. QSAR Analysis of Poliovirus Inhibition By Dual Combinations of Antivirals , 2010 .
[40] V. Poroikov,et al. Design, Synthesis and Pharmacological Evaluation of Novel Vanadium-Containing Complexes as Antidiabetic Agents , 2014, PloS one.
[41] Andreas Bender,et al. Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. , 2016, Drug discovery today.
[42] Hongkang Mei,et al. Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..
[43] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[44] G Marcou,et al. QSPR Approach to Predict Nonadditive Properties of Mixtures. Application to Bubble Point Temperatures of Binary Mixtures of Liquids , 2012, Molecular informatics.
[45] J. Praagman. Book reviewClassification and regression trees: Leo BREIMAN, Jerome H. FRIEDMAN, Richard A. OLSHEN and Charles J. STONE The Wadsworth Statistics/Probability Series, Wadsworth, Belmont, 1984, x + 358 pages , 1985 .